ArticleCureus2025
Caught in Transit: Thrombus Traversing a Patent Foramen Ovale.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Embolus in transit vs.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While a patent foramen ovale (PFO) is a very common anatomic variant, thrombus-in-transit through a PFO is a rare and potentially life-threatening event. Such thrombi can lead to paradoxical emboli, causing multi-organ thromboembolic events with significant hemodynamic and functional consequences depending on the affected systems. Here, we present a case of a 65-year-old man with hypertension who arrived with neurologic deficits, found to have an acute left temporal lobe infarction, and was subsequently found to have a saddle pulmonary embolism. Transesophageal echocardiography then revealed a ten-centimeter thrombus-in-transit across a PFO, and he was later found to have a deep vein thrombosis. The PFO was determined to be the source of his systemic and pulmonary emboli. The patient, initially ineligible for thrombolytics, was managed with mechanical thrombectomy and systemic anticoagulation, leading to gradual clinical improvement. The patient stabilized post-thrombectomy and was ultimately discharged. On ambulatory follow-up, the patient was asymptomatic, without further clotting events. Repeat anticardiolipin testing was negative. This case illustrates the critical need for urgent anatomical assessment for PFO in patients presenting with concurrent right- and left-sided thrombi suggestive of paradoxical embolism. Early detection of thrombus-in-transit can guide risk stratification and inform management, which could potentially improve outcomes for patients with complex thromboembolic presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.